Pharynx bacteria study for high-risk partners
Part of Brain & nervous system, Infections clinical trials.
This trial analyzes throat bacteria in partners of people with gonorrhea to better understand the infection. It may help improve detection and care for those at risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been told you may be at risk because your partner has gonorrhea.
- You used a digital notification system (SXT) to learn about your risk.
- You have scheduled a standard medical test for gonorrhea.
- You are 18 years or older.
- You can speak and understand English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new vaccine designed to protect against gonorrhea, a common sexually transmitted infection. The study checks how safe the vaccine is and how well it trains the immune system to fight the bacteria.
This trial tests whether taking a single dose of doxycycline after sex can prevent common sexually transmitted infections (STIs) like gonorrhea, chlamydia, and syphilis in men who have sex with men (MSM) in Bangkok.
This study tests whether taking a daily antibiotic (doxycycline) can prevent sexually transmitted infections in people at high risk. If you've had an STI recently and sometimes have sex without condoms, you might be able to join.
This study evaluates a new rapid test for gonorrhea designed for women. You'll provide vaginal swab samples and complete a brief counseling session to help researchers understand how well the test works and whether patients can use it correctly.
This study checks whether a specific lab test (the “gyrA assay”) can detect gonorrhea in people who do not have symptoms. It may help clinicians find gonorrhea more quickly and with the right treatment when symptoms aren’t present.
This trial compares two ways of testing for chlamydia and gonorrhea in people who don't have symptoms. It aims to see if faster, point-of-care testing improves outcomes compared to standard lab testing.
Hear when a new Gonorrhea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.